 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0019119	phenanthrene-9,10-epoxide hydrolase activity	1	8.001820e-6	2.951071e-2	2.951071e-2	1.249716e+5	8.001820e-6	1	8.001820e-6	1.000000e+0	5	1.108586e-4	4.088465e-1	8.176930e-2	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	AKR7A2
GO Molecular Function	GO:0004301	epoxide hydrolase activity	2	1.711221e-4	6.310983e-1	3.155492e-1	5.843782e+3	1.711221e-4	1	1.711221e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	3.406676e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	AKR7A2
GO Molecular Function	GO:0016803	ether hydrolase activity	3	2.459798e-4	9.071735e-1	3.023912e-1	4.065375e+3	2.459798e-4	1	2.459798e-4	1.000000e+0	7	7.758812e-4	1.000000e+0	4.087786e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	AKR7A2
GO Molecular Function	GO:0004032	alditol:NADP+ 1-oxidoreductase activity	4	2.644592e-4	9.753255e-1	2.438314e-1	3.781302e+3	2.644592e-4	1	2.644592e-4	1.000000e+0	7	7.758812e-4	1.000000e+0	4.087786e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	AKR7A2
GO Molecular Function	GO:0016801	hydrolase activity, acting on ether bonds	5	4.278125e-4	1.000000e+0	3.155545e-1	2.337473e+3	4.278125e-4	1	4.278125e-4	1.000000e+0	9	1.108309e-3	1.000000e+0	4.541604e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	AKR7A2
GO Molecular Function	GO:0008106	alcohol dehydrogenase (NADP+) activity	6	6.793841e-4	1.000000e+0	4.175948e-1	1.471922e+3	6.793841e-4	1	6.793841e-4	1.000000e+0	10	1.329898e-3	1.000000e+0	4.904664e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	AKR7A2
GO Molecular Function	GO:0004033	aldo-keto reductase (NADP) activity	7	9.014433e-4	1.000000e+0	4.749318e-1	1.109332e+3	9.014433e-4	1	9.014433e-4	1.000000e+0	1	9.402087e-7	3.467490e-3	3.467490e-3	1.002278e+3	1.995455e-3	2	18	1.000000e+0	1.111111e-1	unnamed	AKR7A2,AKR7A3
GO Molecular Function	GO:0009055	electron carrier activity	8	5.710295e-3	1.000000e+0	1.000000e+0	1.751223e+2	5.710295e-3	1	5.710295e-3	1.000000e+0	2	2.091196e-5	7.712331e-2	3.856165e-2	2.173614e+2	9.201264e-3	2	83	1.000000e+0	2.409639e-2	unnamed	AKR7A2,AKR7A3
GO Molecular Function	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	9	8.727475e-3	1.000000e+0	1.000000e+0	1.145807e+2	8.727475e-3	1	8.727475e-3	1.000000e+0	3	4.170102e-5	1.537934e-1	5.126445e-2	1.541966e+2	1.297046e-2	2	117	1.000000e+0	1.709402e-2	unnamed	AKR7A2,AKR7A3
GO Molecular Function	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	10	1.026226e-2	1.000000e+0	1.000000e+0	9.744446e+1	1.026226e-2	1	1.026226e-2	1.000000e+0	4	5.232600e-5	1.929783e-1	4.824457e-2	1.377176e+2	1.452248e-2	2	131	1.000000e+0	1.526718e-2	unnamed	AKR7A2,AKR7A3
GO Molecular Function	GO:0016491	oxidoreductase activity	11	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	11	1.568582e-3	1.000000e+0	5.259028e-1	2.523217e+1	7.926390e-2	2	715	1.000000e+0	2.797203e-3	unnamed	AKR7A2,AKR7A3
GO Molecular Function	GO:0016787	hydrolase activity	12	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	13	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	AKR7A2
GO Molecular Function	GO:0003824	catalytic activity	13	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	12	9.272591e-2	1.000000e+0	1.000000e+0	3.283764e+0	6.090571e-1	2	5494	1.000000e+0	3.640335e-4	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0044598	doxorubicin metabolic process	1	5.394336e-4	1.000000e+0	1.000000e+0	1.853796e+3	5.394336e-4	1	5.394336e-4	1.000000e+0	2	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	AKR7A2
GO Biological Process	GO:0044597	daunorubicin metabolic process	1	5.394336e-4	1.000000e+0	1.000000e+0	1.853796e+3	5.394336e-4	1	5.394336e-4	1.000000e+0	2	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	AKR7A2
GO Biological Process	GO:0030638	polyketide metabolic process	3	6.558263e-4	1.000000e+0	1.000000e+0	1.524794e+3	6.558263e-4	1	6.558263e-4	1.000000e+0	4	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	AKR7A2
GO Biological Process	GO:0016137	glycoside metabolic process	4	6.941718e-4	1.000000e+0	1.000000e+0	1.440566e+3	6.941718e-4	1	6.941718e-4	1.000000e+0	5	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	AKR7A2
GO Biological Process	GO:1901661	quinone metabolic process	5	1.642802e-3	1.000000e+0	1.000000e+0	6.087160e+2	1.642802e-3	1	1.642802e-3	1.000000e+0	7	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	AKR7A2
GO Biological Process	GO:0006081	cellular aldehyde metabolic process	6	3.083768e-3	1.000000e+0	1.000000e+0	3.242786e+2	3.083768e-3	1	3.083768e-3	1.000000e+0	1	4.793221e-6	5.004123e-2	5.004123e-2	4.510250e+2	4.434344e-3	2	40	1.000000e+0	5.000000e-2	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0019748	secondary metabolic process	7	3.742738e-3	1.000000e+0	1.000000e+0	2.671841e+2	3.742738e-3	1	3.742738e-3	1.000000e+0	8	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	AKR7A2
GO Biological Process	GO:0042180	cellular ketone metabolic process	8	3.770613e-3	1.000000e+0	1.000000e+0	2.652089e+2	3.770613e-3	1	3.770613e-3	1.000000e+0	9	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	AKR7A2
GO Biological Process	GO:0051186	cofactor metabolic process	9	2.040573e-2	1.000000e+0	1.000000e+0	4.900585e+1	2.040573e-2	1	2.040573e-2	1.000000e+0	10	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	AKR7A2
GO Biological Process	GO:1901657	glycosyl compound metabolic process	10	4.374541e-2	1.000000e+0	1.000000e+0	2.285954e+1	4.374541e-2	1	4.374541e-2	1.000000e+0	12	6.208551e-2	1.000000e+0	1.000000e+0	1.585325e+1	6.307854e-2	1	569	5.000000e-1	1.757469e-3	unnamed	AKR7A2
GO Biological Process	GO:0005975	carbohydrate metabolic process	11	7.097916e-2	1.000000e+0	1.000000e+0	1.408864e+1	7.097916e-2	1	7.097916e-2	1.000000e+0	13	8.120541e-2	1.000000e+0	1.000000e+0	1.205949e+1	8.292223e-2	1	748	5.000000e-1	1.336898e-3	unnamed	AKR7A2
GO Biological Process	GO:0055114	oxidation-reduction process	12	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	6	2.614782e-3	1.000000e+0	1.000000e+0	1.954605e+1	1.023225e-1	2	923	1.000000e+0	2.166847e-3	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	13	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	14	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	AKR7A2
GO Biological Process	GO:0044281	small molecule metabolic process	14	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	17	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	AKR7A2
GO Biological Process	GO:0044710	single-organism metabolic process	15	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	11	2.877979e-2	1.000000e+0	1.000000e+0	5.893826e+0	3.393382e-1	2	3061	1.000000e+0	6.533812e-4	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0006807	nitrogen compound metabolic process	16	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	19	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	AKR7A2
GO Biological Process	GO:0044237	cellular metabolic process	17	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	15	2.082916e-1	1.000000e+0	1.000000e+0	2.191037e+0	9.128097e-1	2	8234	1.000000e+0	2.428953e-4	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0044238	primary metabolic process	18	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	21	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	AKR7A2
GO Biological Process	GO:0071704	organic substance metabolic process	19	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	16	2.252177e-1	1.000000e+0	1.000000e+0	2.107101e+0	9.491713e-1	2	8562	1.000000e+0	2.335903e-4	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0008152	metabolic process	20	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	18	2.598086e-1	1.000000e+0	1.000000e+0	1.961831e+0	1.019456e+0	2	9196	1.000000e+0	2.174859e-4	unnamed	AKR7A2,AKR7A3
GO Biological Process	GO:0009987	cellular process	21	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	20	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0005794	Golgi apparatus	1	1.250692e-1	1.000000e+0	1.000000e+0	7.995574e+0	1.250692e-1	1	1.250692e-1	1.000000e+0	1	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	AKR7A2
GO Cellular Component	GO:0005829	cytosol	2	2.084988e-1	1.000000e+0	1.000000e+0	4.796191e+0	2.084988e-1	1	2.084988e-1	1.000000e+0	3	2.663307e-1	1.000000e+0	1.000000e+0	3.485510e+0	2.869021e-1	1	2588	5.000000e-1	3.863988e-4	unnamed	AKR7A3
GO Cellular Component	GO:0044444	cytoplasmic part	3	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	2	1.519576e-1	1.000000e+0	1.000000e+0	2.565193e+0	7.796685e-1	2	7033	1.000000e+0	2.843737e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0005737	cytoplasm	4	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	4	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	5	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	9	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	AKR7A2
GO Cellular Component	GO:0043227	membrane-bounded organelle	6	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	10	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	AKR7A2
GO Cellular Component	GO:0043229	intracellular organelle	7	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	11	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	AKR7A2
GO Cellular Component	GO:0043226	organelle	8	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	12	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	AKR7A2
GO Cellular Component	GO:0044424	intracellular part	9	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	5	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0005622	intracellular	10	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	6	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0044464	cell part	11	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	7	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	AKR7A2,AKR7A3
GO Cellular Component	GO:0005623	cell	12	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	8	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	AKR7A2,AKR7A3
Disease Ontology	DOID:162	cancer	1	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	1	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	AKR7A2
Disease Ontology	DOID:4	disease	2	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	2	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	AKR7A2
MSigDB Cancer Neighborhood	GNF2_TST	Neighborhood of TST	1	3.672715e-3	1.000000e+0	1.000000e+0	2.722782e+2	3.672715e-3	1	3.672715e-3	1.000000e+0	4	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	AKR7A3
MSigDB Cancer Neighborhood	MORF_DAP	Neighborhood of DAP	2	3.980219e-3	1.000000e+0	8.497768e-1	2.512425e+2	3.980219e-3	1	3.980219e-3	1.000000e+0	2	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_DEAF1	Neighborhood of DEAF1	3	4.081884e-3	1.000000e+0	5.809882e-1	2.449849e+2	4.081884e-3	1	4.081884e-3	1.000000e+0	1	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	AKR7A2
MSigDB Cancer Neighborhood	GNF2_GSTM1	Neighborhood of GSTM1	4	4.115918e-3	1.000000e+0	4.393742e-1	2.429592e+2	4.115918e-3	1	4.115918e-3	1.000000e+0	7	1.193722e-2	1.000000e+0	7.281704e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	AKR7A3
MSigDB Cancer Neighborhood	GNF2_LCAT	Neighborhood of LCAT	5	4.847474e-3	1.000000e+0	4.139743e-1	2.062930e+2	4.847474e-3	1	4.847474e-3	1.000000e+0	8	1.358950e-2	1.000000e+0	7.253396e-1	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	AKR7A3
MSigDB Cancer Neighborhood	MORF_MAP2K2	Neighborhood of MAP2K2	6	5.257913e-3	1.000000e+0	3.741881e-1	1.901895e+2	5.257913e-3	1	5.257913e-3	1.000000e+0	9	1.447015e-2	1.000000e+0	6.865282e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_MTA1	Neighborhood of MTA1	7	5.358871e-3	1.000000e+0	3.268911e-1	1.866065e+2	5.358871e-3	1	5.358871e-3	1.000000e+0	4	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	GNF2_HPN	Neighborhood of HPN	8	5.478107e-3	1.000000e+0	2.923940e-1	1.825448e+2	5.478107e-3	1	5.478107e-3	1.000000e+0	10	1.458020e-2	1.000000e+0	6.225745e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	AKR7A3
MSigDB Cancer Neighborhood	GNF2_HPX	Neighborhood of HPX	9	5.636754e-3	1.000000e+0	2.674327e-1	1.774071e+2	5.636754e-3	1	5.636754e-3	1.000000e+0	11	1.480029e-2	1.000000e+0	5.745203e-1	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	AKR7A3
MSigDB Cancer Neighborhood	MORF_PRDX3	Neighborhood of PRDX3	10	6.156751e-3	1.000000e+0	2.628933e-1	1.624233e+2	6.156751e-3	1	6.156751e-3	1.000000e+0	3	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_PTPN11	Neighborhood of PTPN11	11	6.198230e-3	1.000000e+0	2.406040e-1	1.613364e+2	6.198230e-3	1	6.198230e-3	1.000000e+0	6	1.182702e-2	1.000000e+0	8.416896e-1	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_EI24	Neighborhood of EI24	12	9.443389e-3	1.000000e+0	3.360273e-1	1.058942e+2	9.443389e-3	1	9.443389e-3	1.000000e+0	12	1.601034e-2	1.000000e+0	5.697013e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_RFC4	Neighborhood of RFC4	13	1.096595e-2	1.000000e+0	3.601893e-1	9.119140e+1	1.096595e-2	1	1.096595e-2	1.000000e+0	13	1.645017e-2	1.000000e+0	5.403248e-1	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_HAT1	Neighborhood of HAT1	14	1.209821e-2	1.000000e+0	3.689954e-1	8.265689e+1	1.209821e-2	1	1.209821e-2	1.000000e+0	15	1.930669e-2	1.000000e+0	5.495971e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_PRKDC	Neighborhood of PRKDC	15	1.236538e-2	1.000000e+0	3.520012e-1	8.087092e+1	1.236538e-2	1	1.236538e-2	1.000000e+0	16	2.106249e-2	1.000000e+0	5.621052e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_PPP1CC	Neighborhood of PPP1CC	16	1.291401e-2	1.000000e+0	3.446426e-1	7.743529e+1	1.291401e-2	1	1.291401e-2	1.000000e+0	14	1.809867e-2	1.000000e+0	5.520094e-1	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_EIF3S2	Neighborhood of EIF3S2	17	1.367609e-2	1.000000e+0	3.435112e-1	7.312033e+1	1.367609e-2	1	1.367609e-2	1.000000e+0	18	2.708603e-2	1.000000e+0	6.425408e-1	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_HDAC1	Neighborhood of HDAC1	18	1.408654e-2	1.000000e+0	3.341640e-1	7.098976e+1	1.408654e-2	1	1.408654e-2	1.000000e+0	19	2.817922e-2	1.000000e+0	6.332909e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_CSNK2B	Neighborhood of CSNK2B	19	1.463860e-2	1.000000e+0	3.289833e-1	6.831256e+1	1.463860e-2	1	1.463860e-2	1.000000e+0	23	3.167331e-2	1.000000e+0	5.880219e-1	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_XRCC5	Neighborhood of XRCC5	20	1.540870e-2	1.000000e+0	3.289757e-1	6.489838e+1	1.540870e-2	1	1.540870e-2	1.000000e+0	17	2.621103e-2	1.000000e+0	6.583594e-1	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_BUB3	Neighborhood of BUB3	21	1.577193e-2	1.000000e+0	3.206959e-1	6.340380e+1	1.577193e-2	1	1.577193e-2	1.000000e+0	20	3.058208e-2	1.000000e+0	6.529274e-1	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_SOD1	Neighborhood of SOD1	22	1.778344e-2	1.000000e+0	3.451604e-1	5.623208e+1	1.778344e-2	1	1.778344e-2	1.000000e+0	22	3.080038e-2	1.000000e+0	5.978074e-1	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_HDAC2	Neighborhood of HDAC2	23	2.010072e-2	1.000000e+0	3.731742e-1	4.974947e+1	2.010072e-2	1	2.010072e-2	1.000000e+0	20	3.058208e-2	1.000000e+0	6.529274e-1	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_GNB1	Neighborhood of GNB1	24	2.039438e-2	1.000000e+0	3.628500e-1	4.903311e+1	2.039438e-2	1	2.039438e-2	1.000000e+0	24	3.363597e-2	1.000000e+0	5.984400e-1	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	AKR7A2
MSigDB Cancer Neighborhood	MORF_RAD23A	Neighborhood of RAD23A	25	2.178384e-2	1.000000e+0	3.720680e-1	4.590559e+1	2.178384e-2	1	2.178384e-2	1.000000e+0	25	3.842519e-2	1.000000e+0	6.563022e-1	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	AKR7A2
MSigDB Perturbation	VALK_AML_CLUSTER_16	Top 40 genes from cluster 16 of acute myeloid leukemia (AML) expression profile; 81% of the samples are FAB M5 subtype, 45% have 11q23 abnormalities.	1	4.031461e-3	1.000000e+0	1.000000e+0	2.480490e+2	4.031461e-3	1	4.031461e-3	1.000000e+0	6	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	AKR7A2
MSigDB Perturbation	MELLMAN_TUT1_TARGETS_DN	Genes down-regulated in HEK293 cells (embryo kidney) after knockdown of TUT1 [GeneID=64852] by RNAi.	2	4.597196e-3	1.000000e+0	1.000000e+0	2.175239e+2	4.597196e-3	1	4.597196e-3	1.000000e+0	7	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	AKR7A2
MSigDB Perturbation	ROSS_AML_WITH_MLL_FUSIONS	Top 100 probe sets for pediatric acute myeloid leukemia (AML) subtypes with chimeric MLL fusions [GeneID=4297].	3	6.509977e-3	1.000000e+0	1.000000e+0	1.536104e+2	6.509977e-3	1	6.509977e-3	1.000000e+0	8	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	AKR7A2
MSigDB Perturbation	MAHAJAN_RESPONSE_TO_IL1A_UP	Genes up-regulated in corneal fibroblasts after treatment with IL1A [GeneID=3552].	4	8.368845e-3	1.000000e+0	1.000000e+0	1.194908e+2	8.368845e-3	1	8.368845e-3	1.000000e+0	11	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	AKR7A3
MSigDB Perturbation	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	Top 100 probe sets associated with MLL fusions [GeneID=4297] irrespective of the lineage of the pediatric acute leukemia.	5	8.750573e-3	1.000000e+0	1.000000e+0	1.142782e+2	8.750573e-3	1	8.750573e-3	1.000000e+0	8	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	AKR7A2
MSigDB Perturbation	HOEBEKE_LYMPHOID_STEM_CELL_DN	Genes down-regulated in the common lymphoid progenitor (CLP, defined as CD34+CD38-CD7+ [GeneID=947;952;924]) compared to a multipotent cord blood cell (defined as CD34+CD38+CD7-).	6	9.890082e-3	1.000000e+0	1.000000e+0	1.011114e+2	9.890082e-3	1	9.890082e-3	1.000000e+0	12	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	AKR7A2
MSigDB Perturbation	GRADE_COLON_AND_RECTAL_CANCER_DN	Down-regulated genes in both rectal and colon carcinoma compared to normal mucosa samples.	7	1.105162e-2	1.000000e+0	1.000000e+0	9.048447e+1	1.105162e-2	1	1.105162e-2	1.000000e+0	13	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	AKR7A2
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	Genes commonly up-regulated in CD-1 and CD-2 clusters of multiple myeloma samples and which were higher expressed in the CD-1 group.	8	1.249098e-2	1.000000e+0	1.000000e+0	8.005779e+1	1.249098e-2	1	1.249098e-2	1.000000e+0	10	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	AKR7A2
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	Top 200 marker genes down-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	9	1.416646e-2	1.000000e+0	1.000000e+0	7.058926e+1	1.416646e-2	1	1.416646e-2	1.000000e+0	15	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	AKR7A3
MSigDB Perturbation	PENG_RAPAMYCIN_RESPONSE_UP	Genes up-regulated in BJUB cells (B-lymphoma) in response to  rapamycin [PubChem=6610346] treatment.	10	1.460801e-2	1.000000e+0	1.000000e+0	6.845558e+1	1.460801e-2	1	1.460801e-2	1.000000e+0	16	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	AKR7A3
MSigDB Perturbation	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	Genes identified as synthetic lethal with imatinib [PubChemID=5291] in RNAi screen in K562 cells (CML, chronic myelogenous leukemia).	11	1.564627e-2	1.000000e+0	1.000000e+0	6.391301e+1	1.564627e-2	1	1.564627e-2	1.000000e+0	14	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	AKR7A2
MSigDB Perturbation	ALONSO_METASTASIS_UP	Up-regulated genes in melanoma tumous that developed metastatic disease compared to primary melanoma that did not.	12	1.864850e-2	1.000000e+0	1.000000e+0	5.362362e+1	1.864850e-2	1	1.864850e-2	1.000000e+0	18	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	AKR7A2
MSigDB Perturbation	VERHAAK_GLIOBLASTOMA_MESENCHYMAL	Genes correlated with mesenchymal type of glioblastoma multiforme tumors.	13	2.069837e-2	1.000000e+0	1.000000e+0	4.831299e+1	2.069837e-2	1	2.069837e-2	1.000000e+0	17	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	AKR7A3
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	Genes down-regulated in liver tumor compared to the normal adjacent tissue.	14	2.113154e-2	1.000000e+0	1.000000e+0	4.732263e+1	2.113154e-2	1	2.113154e-2	1.000000e+0	19	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	AKR7A3
MSigDB Perturbation	MULLIGHAN_MLL_SIGNATURE_1_UP	The 'MLL signature 1': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to all AML cases with the intact gene.	15	2.318792e-2	1.000000e+0	1.000000e+0	4.312591e+1	2.318792e-2	1	2.318792e-2	1.000000e+0	2	4.172315e-4	1.000000e+0	7.017834e-1	4.889160e+1	4.090682e-2	2	369	1.000000e+0	5.420054e-3	unnamed	AKR7A2,AKR7A3
MSigDB Perturbation	LIU_SOX4_TARGETS_DN	Genes down-regulated in LNCaP cells (prostate cancer) by overexpression of SOX4 [GeneID=6659] and up-regulated by its RNAi knockdown.	16	2.380380e-2	1.000000e+0	1.000000e+0	4.201010e+1	2.380380e-2	1	2.380380e-2	1.000000e+0	20	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	AKR7A2
MSigDB Perturbation	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	Genes down-regulated in normal tissue adjacent to liver tumor, compared to the normal liver samples.	17	2.469410e-2	1.000000e+0	1.000000e+0	4.049551e+1	2.469410e-2	1	2.469410e-2	1.000000e+0	23	4.005517e-2	1.000000e+0	1.000000e+0	2.471370e+1	4.046339e-2	1	365	5.000000e-1	2.739726e-3	unnamed	AKR7A3
MSigDB Perturbation	MULLIGHAN_MLL_SIGNATURE_2_UP	The 'MLL signature 2': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to the AML cases with intact MLL and NPM1 [GeneID=4869].	18	2.570756e-2	1.000000e+0	1.000000e+0	3.889906e+1	2.570756e-2	1	2.570756e-2	1.000000e+0	3	5.052239e-4	1.000000e+0	5.665244e-1	4.443596e+1	4.500859e-2	2	406	1.000000e+0	4.926108e-3	unnamed	AKR7A2,AKR7A3
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	19	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	22	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	AKR7A2
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	Down-regulated genes whose expression profile is specific to Custer I of urothelial cell carcinoma (UCC) tumors.	20	2.961689e-2	1.000000e+0	1.000000e+0	3.376452e+1	2.961689e-2	1	2.961689e-2	1.000000e+0	24	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	AKR7A2
MSigDB Perturbation	WANG_LMO4_TARGETS_UP	Genes up-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system.	21	3.656950e-2	1.000000e+0	1.000000e+0	2.734519e+1	3.656950e-2	1	3.656950e-2	1.000000e+0	1	3.667736e-4	1.000000e+0	1.000000e+0	5.214162e+1	3.835708e-2	2	346	1.000000e+0	5.780347e-3	unnamed	AKR7A2,AKR7A3
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_DN	Genes down-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	22	4.027354e-2	1.000000e+0	1.000000e+0	2.483020e+1	4.027354e-2	1	4.027354e-2	1.000000e+0	30	5.810880e-2	1.000000e+0	1.000000e+0	1.695583e+1	5.897678e-2	1	532	5.000000e-1	1.879699e-3	unnamed	AKR7A3
MSigDB Perturbation	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	Genes which best discriminated between two groups of breast cancer according to the status of ESR1 and AR [GeneID=2099;367]: basal (ESR1- AR-) and luminal (ESR1+ AR+).	23	4.119949e-2	1.000000e+0	1.000000e+0	2.427215e+1	4.119949e-2	1	4.119949e-2	1.000000e+0	21	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	AKR7A3
MSigDB Perturbation	CUI_TCF21_TARGETS_2_UP	All significantly up-regulated genes in kidney glomeruli isolated from TCF21 [Gene ID=6943] knockout mice.	24	4.545878e-2	1.000000e+0	1.000000e+0	2.199795e+1	4.545878e-2	1	4.545878e-2	1.000000e+0	26	4.547842e-2	1.000000e+0	1.000000e+0	2.173614e+1	4.600632e-2	1	415	5.000000e-1	2.409639e-3	unnamed	AKR7A2
MSigDB Perturbation	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	Genes regulated in MCF7 cells (breast cancer) by expression of the truncated (611-CTF) form of ERBB2 [GeneID=2064] at 60 h time point.	25	4.682954e-2	1.000000e+0	1.000000e+0	2.135404e+1	4.682954e-2	1	4.682954e-2	1.000000e+0	25	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	AKR7A2
MSigDB Perturbation	PARENT_MTOR_SIGNALING_UP	Genes up-regulated in HepaRG cells (liver cancer) expressing constituvely active form of MTOR [GeneID=2475].	26	5.070875e-2	1.000000e+0	1.000000e+0	1.972046e+1	5.070875e-2	1	5.070875e-2	1.000000e+0	33	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	AKR7A2
MSigDB Perturbation	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	Genes with copy number losses in primary neuroblastoma tumors.	27	5.143070e-2	1.000000e+0	1.000000e+0	1.944364e+1	5.143070e-2	1	5.143070e-2	1.000000e+0	5	1.680270e-3	1.000000e+0	1.000000e+0	2.437973e+1	8.203536e-2	2	740	1.000000e+0	2.702703e-3	unnamed	AKR7A2,AKR7A3
MSigDB Perturbation	BENPORATH_MYC_MAX_TARGETS	Set 'Myc targets2': targets of c-Myc [GeneID=4609] and Max [GeneID=4149] identified by ChIP on chip in a Burkitt's lymphoma cell line; overlap set.	28	5.249114e-2	1.000000e+0	1.000000e+0	1.905083e+1	5.249114e-2	1	5.249114e-2	1.000000e+0	36	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	AKR7A2
MSigDB Perturbation	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	Genes up-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).	29	5.507944e-2	1.000000e+0	1.000000e+0	1.815559e+1	5.507944e-2	1	5.507944e-2	1.000000e+0	34	6.090412e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	558	5.000000e-1	1.792115e-3	unnamed	AKR7A2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not down-regulated at the previous time point, 24 h.	30	5.544365e-2	1.000000e+0	1.000000e+0	1.803633e+1	5.544365e-2	1	5.544365e-2	1.000000e+0	27	5.369234e-2	1.000000e+0	1.000000e+0	1.837169e+1	5.443157e-2	1	491	5.000000e-1	2.036660e-3	unnamed	AKR7A3
MSigDB Perturbation	CHICAS_RB1_TARGETS_SENESCENT	Genes up-regulated in senescent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	31	5.829074e-2	1.000000e+0	1.000000e+0	1.715538e+1	5.829074e-2	1	5.829074e-2	1.000000e+0	32	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	AKR7A2
MSigDB Perturbation	WEST_ADRENOCORTICAL_TUMOR_DN	Down-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	32	5.877938e-2	1.000000e+0	1.000000e+0	1.701277e+1	5.877938e-2	1	5.877938e-2	1.000000e+0	31	5.864668e-2	1.000000e+0	1.000000e+0	1.679795e+1	5.953107e-2	1	537	5.000000e-1	1.862197e-3	unnamed	AKR7A2
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	Genes down-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 6 h.	33	6.223242e-2	1.000000e+0	1.000000e+0	1.606879e+1	6.223242e-2	1	6.223242e-2	1.000000e+0	29	5.638653e-2	1.000000e+0	1.000000e+0	1.748159e+1	5.720304e-2	1	516	5.000000e-1	1.937984e-3	unnamed	AKR7A2
MSigDB Perturbation	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	Genes down-regulated in kidney biopsies from patients with acute transplant rejection compared to the biopsies from patients with well functioning kidneys more than 1-year post transplant.	34	6.264225e-2	1.000000e+0	1.000000e+0	1.596367e+1	6.264225e-2	1	6.264225e-2	1.000000e+0	4	9.042780e-4	1.000000e+0	7.604978e-1	3.322468e+1	6.019622e-2	2	543	1.000000e+0	3.683241e-3	unnamed	AKR7A2,AKR7A3
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_DN	Genes down-regulated in uveal melanoma: class 2 vs class 1 tumors.	35	6.267829e-2	1.000000e+0	1.000000e+0	1.595449e+1	6.267829e-2	1	6.267829e-2	1.000000e+0	28	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	AKR7A2
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	36	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	38	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	AKR7A2
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_DN	Genes down-regulated in basal subtype of breast cancer samles.	37	8.172677e-2	1.000000e+0	1.000000e+0	1.223589e+1	8.172677e-2	1	8.172677e-2	1.000000e+0	35	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	AKR7A3
MSigDB Perturbation	BENPORATH_SUZ12_TARGETS	Set 'Suz12 targets': genes identified by ChIP on chip as targets of the Polycomb protein SUZ12 [GeneID=23512] in human embryonic stem cells.	38	1.616879e-1	1.000000e+0	1.000000e+0	6.184754e+0	1.616879e-1	1	1.616879e-1	1.000000e+0	37	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	AKR7A2
MSigDB Predicted Promoter Motifs	YAATNANRNNNCAG_UNKNOWN	Motif YAATNANRNNNCAG (no known TF)	1	7.938258e-3	1.000000e+0	1.000000e+0	1.259722e+2	7.938258e-3	1	7.938258e-3	1.000000e+0	1	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	AKR7A2
MSigDB Predicted Promoter Motifs	TCANNTGAY_V$SREBP1_01	Motif TCANNTGAY matches SREBF1: sterol regulatory element binding transcription factor 1	2	4.619989e-2	1.000000e+0	1.000000e+0	2.164507e+1	4.619989e-2	1	4.619989e-2	1.000000e+0	2	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	AKR7A2
MSigDB Predicted Promoter Motifs	RCGCANGCGY_V$NRF1_Q6	Motif RCGCANGCGY matches NRF1: nuclear respiratory factor 1	3	6.425044e-2	1.000000e+0	1.000000e+0	1.556410e+1	6.425044e-2	1	6.425044e-2	1.000000e+0	3	9.486248e-2	1.000000e+0	1.000000e+0	1.028563e+1	9.722299e-2	1	877	5.000000e-1	1.140251e-3	unnamed	AKR7A2
MSigDB Predicted Promoter Motifs	CAGCTG_V$AP4_Q5	Motif CAGCTG matches REPIN1: replication initiator 1	4	1.626399e-1	1.000000e+0	1.000000e+0	6.148551e+0	1.626399e-1	1	1.626399e-1	1.000000e+0	4	1.532695e-1	1.000000e+0	1.000000e+0	6.264236e+0	1.596364e-1	1	1440	5.000000e-1	6.944444e-4	unnamed	AKR7A2
MSigDB Predicted Promoter Motifs	GGGCGGR_V$SP1_Q6	Motif GGGCGGR matches SP1: Sp1 transcription factor	5	2.425080e-1	1.000000e+0	1.000000e+0	4.123575e+0	2.425080e-1	1	2.425080e-1	1.000000e+0	5	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	AKR7A2
InterPro	IPR001395	Aldo/keto reductase	1	1.162818e-3	1.000000e+0	1.000000e+0	8.599802e+2	1.162818e-3	1	1.162818e-3	1.000000e+0	1	7.374186e-7	6.947958e-3	6.947958e-3	1.127562e+3	1.773738e-3	2	16	1.000000e+0	1.250000e-1	unnamed	AKR7A2,AKR7A3
InterPro	IPR023210	NADP-dependent oxidoreductase domain	2	1.245270e-3	1.000000e+0	1.000000e+0	8.030385e+2	1.245270e-3	1	1.245270e-3	1.000000e+0	2	8.357411e-7	7.874353e-3	3.937176e-3	1.061235e+3	1.884596e-3	2	17	1.000000e+0	1.176471e-1	unnamed	AKR7A2,AKR7A3
TreeFam	TF329173	AKR7A2, AKR7A3	1	2.117672e-5	1.720820e-1	1.720820e-1	4.722166e+4	2.117672e-5	1	2.117672e-5	1.000000e+0	1	6.145155e-9	4.993553e-5	4.993553e-5	9.020500e+3	2.217172e-4	2	2	1.000000e+0	1.000000e+0	unnamed	AKR7A2,AKR7A3
HGNC Gene Families	AKR	AKR	1	8.416645e-4	4.023156e-1	4.023156e-1	1.188122e+3	8.416645e-4	1	8.416645e-4	1.000000e+0	1	4.055802e-7	1.938673e-4	1.938673e-4	1.503417e+3	1.330303e-3	2	12	1.000000e+0	1.666667e-1	unnamed	AKR7A2,AKR7A3
Ensembl Genes	262	AKR7A2	1	8.001820e-6	1.443608e-1	1.443608e-1	1.249716e+5	8.001820e-6	1	8.001820e-6	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	AKR7A2
Ensembl Genes	261	AKR7A3	2	1.774513e-5	3.201399e-1	1.600699e-1	5.635350e+4	1.774513e-5	1	1.774513e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	AKR7A3
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.	1	1.190622e-2	1.000000e+0	1.000000e+0	8.398968e+1	1.190622e-2	1	1.190622e-2	1.000000e+0	1	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	Genes up-regulated in comparison of IgD+ peripheral blood B cells versus IgD- naive tonsil B cells.	2	1.201537e-2	1.000000e+0	1.000000e+0	8.322673e+1	1.201537e-2	1	1.201537e-2	1.000000e+0	42	2.193980e-2	1.000000e+0	9.977385e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	AKR7A3
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 1 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	3	1.276108e-2	1.000000e+0	1.000000e+0	7.836330e+1	1.276108e-2	1	1.276108e-2	1.000000e+0	42	2.193980e-2	1.000000e+0	9.977385e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 1.5 h versus those at 72 h.	4	1.332361e-2	1.000000e+0	1.000000e+0	7.505475e+1	1.332361e-2	1	1.332361e-2	1.000000e+0	5	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 4 h.	5	1.343409e-2	1.000000e+0	1.000000e+0	7.443750e+1	1.343409e-2	1	1.343409e-2	1.000000e+0	30	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with LPS (TLR4 agonist) at 8 h.	6	1.350184e-2	1.000000e+0	1.000000e+0	7.406396e+1	1.350184e-2	1	1.350184e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus those stimulated at 24 h.	7	1.357048e-2	1.000000e+0	1.000000e+0	7.368937e+1	1.357048e-2	1	1.357048e-2	1.000000e+0	30	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.	8	1.358914e-2	1.000000e+0	1.000000e+0	7.358818e+1	1.358914e-2	1	1.358914e-2	1.000000e+0	48	2.336458e-2	1.000000e+0	9.297156e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with CpG DNA (TLR9 agonist) at 6 h.	9	1.384869e-2	1.000000e+0	1.000000e+0	7.220899e+1	1.384869e-2	1	1.384869e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	10	1.427335e-2	1.000000e+0	1.000000e+0	7.006063e+1	1.427335e-2	1	1.427335e-2	1.000000e+0	13	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 8 h versus those stimulated with Gardiquimod (TLR7 agonist) at 8 h.	11	1.458119e-2	1.000000e+0	1.000000e+0	6.858152e+1	1.458119e-2	1	1.458119e-2	1.000000e+0	16	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	12	1.467969e-2	1.000000e+0	1.000000e+0	6.812132e+1	1.467969e-2	1	1.467969e-2	1.000000e+0	13	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE5960_TH1_VS_ANERGIC_TH1_UP	Genes up-regulated in comparison of anergy induced CD4 [GeneID=920] T cells versus conventional CD4 [GeneID=920] T cells.	13	1.472860e-2	1.000000e+0	1.000000e+0	6.789513e+1	1.472860e-2	1	1.472860e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE10325_BCELL_VS_LUPUS_BCELL_UP	Genes up-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.	14	1.475708e-2	1.000000e+0	1.000000e+0	6.776409e+1	1.475708e-2	1	1.475708e-2	1.000000e+0	3	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	AKR7A3
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 8 h.	15	1.520446e-2	1.000000e+0	1.000000e+0	6.577018e+1	1.520446e-2	1	1.520446e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB3 [GeneID=7043] and IL6 [GeneID=3569] versus those treated with TGF3B [GeneID=7043], IL6 [GeneID=3569] and IL23A [GeneID=51561].	16	1.521143e-2	1.000000e+0	1.000000e+0	6.574003e+1	1.521143e-2	1	1.521143e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 6 h versus those stimulated with Gardiquimod (TLR7 agonist) at 6 h.	17	1.528908e-2	1.000000e+0	1.000000e+0	6.540618e+1	1.528908e-2	1	1.528908e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 12 h versus those stimulated with Gardiquimod (TLR7 agonist) at 12 h.	18	1.533954e-2	1.000000e+0	1.000000e+0	6.519101e+1	1.533954e-2	1	1.533954e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_GARDIQUIMOD_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 12 h versus those stimulated with Gardiquimod (TLR7 agonist) at 24 h.	19	1.540955e-2	1.000000e+0	1.000000e+0	6.489480e+1	1.540955e-2	1	1.540955e-2	1.000000e+0	46	2.215906e-2	1.000000e+0	9.200827e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	20	1.564725e-2	1.000000e+0	1.000000e+0	6.390901e+1	1.564725e-2	1	1.564725e-2	1.000000e+0	1	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of neutrophils versus effector memory CD4 [GeneID=920] T cells.	21	1.569757e-2	1.000000e+0	1.000000e+0	6.370412e+1	1.569757e-2	1	1.569757e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_BCELL_DN	Genes down-regulated in comparison of neutrophils versus B cells.	22	1.594138e-2	1.000000e+0	1.000000e+0	6.272981e+1	1.594138e-2	1	1.594138e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.	23	1.597043e-2	1.000000e+0	1.000000e+0	6.261572e+1	1.597043e-2	1	1.597043e-2	1.000000e+0	5	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN	Genes down-regulated in comparsion of ActTregTGF versus ActCD4TGF (see Fig. 1 in the paper for details).	24	1.602297e-2	1.000000e+0	1.000000e+0	6.241042e+1	1.602297e-2	1	1.602297e-2	1.000000e+0	5	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with poly(I:C) (TLR3 agonist) at 1 h.	25	1.606339e-2	1.000000e+0	1.000000e+0	6.225335e+1	1.606339e-2	1	1.606339e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 48 h versus neutrophils stimulated with LPS (TLR4 agonist) at 1 h.	26	1.607700e-2	1.000000e+0	1.000000e+0	6.220065e+1	1.607700e-2	1	1.607700e-2	1.000000e+0	25	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	AKR7A3
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_4H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with LPS (TLR4 agonist) at 4 h.	27	1.628362e-2	1.000000e+0	1.000000e+0	6.141142e+1	1.628362e-2	1	1.628362e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP	Genes up-regulated in comparison of untreated macrophages at 4 h versus those treated with LPS (TLR4 agonist) at 1 h.	28	1.675853e-2	1.000000e+0	1.000000e+0	5.967111e+1	1.675853e-2	1	1.675853e-2	1.000000e+0	4	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_BCELL_DN	Genes down-regulated in comparison of eosinophils versus B cells.	29	1.678553e-2	1.000000e+0	1.000000e+0	5.957512e+1	1.678553e-2	1	1.678553e-2	1.000000e+0	8	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_4H_VS_24H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 4 h versus those stimulated at 24 h.	30	1.690970e-2	1.000000e+0	1.000000e+0	5.913764e+1	1.690970e-2	1	1.690970e-2	1.000000e+0	29	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE27786_LSK_VS_MONO_MAC_UP	Genes up-regulated in comparison of LSK versus monocyte macrophages.	31	1.694451e-2	1.000000e+0	1.000000e+0	5.901615e+1	1.694451e-2	1	1.694451e-2	1.000000e+0	8	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_MONO_MAC_UP	Genes up-regulated in comparison of lineage negative versus monocyte macrophages.	32	1.705984e-2	1.000000e+0	1.000000e+0	5.861718e+1	1.705984e-2	1	1.705984e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 24 h.	33	1.797406e-2	1.000000e+0	1.000000e+0	5.563573e+1	1.797406e-2	1	1.797406e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_LPS_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus those stimulated at 12 h.	34	1.814749e-2	1.000000e+0	1.000000e+0	5.510404e+1	1.814749e-2	1	1.814749e-2	1.000000e+0	12	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	35	1.862210e-2	1.000000e+0	1.000000e+0	5.369962e+1	1.862210e-2	1	1.862210e-2	1.000000e+0	25	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_DC_DN	Genes down-regulated in comparison of mast cells versus dendritic cells (DC).	36	1.901763e-2	1.000000e+0	1.000000e+0	5.258278e+1	1.901763e-2	1	1.901763e-2	1.000000e+0	47	2.237830e-2	1.000000e+0	9.094160e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	37	1.906524e-2	1.000000e+0	9.841786e-1	5.245148e+1	1.906524e-2	1	1.906524e-2	1.000000e+0	30	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.	38	1.907204e-2	1.000000e+0	9.586210e-1	5.243277e+1	1.907204e-2	1	1.907204e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_LPS_4H_MAC_UP	Genes up-regulated in comparison of untreated macrophages versus macrophages treated with LPS (TLR4 agonist) at 4 h.	39	1.913516e-2	1.000000e+0	9.371322e-1	5.225981e+1	1.913516e-2	1	1.913516e-2	1.000000e+0	10	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN	Genes down-regulated in comparison of control CD4 [GeneID=920] CD8 thymocytes versus those after stimulation with anti-Vbeta5 antibodies.	40	1.923300e-2	1.000000e+0	9.183758e-1	5.199396e+1	1.923300e-2	1	1.923300e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major.	41	1.923476e-2	1.000000e+0	8.960583e-1	5.198922e+1	1.923476e-2	1	1.923476e-2	1.000000e+0	42	2.193980e-2	1.000000e+0	9.977385e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA versus total mRNA in dendritic cells.	42	1.954301e-2	1.000000e+0	8.887416e-1	5.116918e+1	1.954301e-2	1	1.954301e-2	1.000000e+0	30	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	43	2.022880e-2	1.000000e+0	8.985351e-1	4.943446e+1	2.022880e-2	1	2.022880e-2	1.000000e+0	16	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	44	2.041558e-2	1.000000e+0	8.862218e-1	4.898221e+1	2.041558e-2	1	2.041558e-2	1.000000e+0	42	2.193980e-2	1.000000e+0	9.977385e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	Genes down-regulated in comparison of eosinophils versus mast cells.	45	2.055038e-2	1.000000e+0	8.722495e-1	4.866091e+1	2.055038e-2	1	2.055038e-2	1.000000e+0	25	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_1H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 1 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 1 h.	46	2.136512e-2	1.000000e+0	8.871169e-1	4.680527e+1	2.136512e-2	1	2.136512e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) versus DCs exposed to B. malayi (5 worms/well).	47	2.276278e-2	1.000000e+0	9.250406e-1	4.393137e+1	2.276278e-2	1	2.276278e-2	1.000000e+0	13	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	AKR7A2
MSigDB Immunologic Signatures	GSE18148_CBFB_KO_VS_WT_TREG_DN	Genes down-regualted in comparison of regulatory T cell (Treg) from CBFB [GeneID=865] deficient mice versus those from wild type animals.	48	2.709295e-2	1.000000e+0	1.000000e+0	3.690997e+1	2.709295e-2	1	2.709295e-2	1.000000e+0	25	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	AKR7A2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
